Who to call at Sino Biopharmaceutical, and when
Fundz watches for the moments Sino Biopharmaceutical starts buying, and tells you who to reach.
- An alert the day Sino Biopharmaceutical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sino Biopharmaceutical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sino Biopharmaceutical. With Fundz connected, it knows.
Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal
Contract Type
partnership
Description
Sino Biopharmaceutical has entered a multi-program partnership with Boehringer Ingelheim, covering six pre-clinical oncology biologics. The agreement involves $358 million in upfront payments and potential milestones totaling up to $7 billion, significantly impacting Sino Biopharmaceutical's investment narrative in oncology.
Quick answer
Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026).
- What agreement did Sino Biopharmaceutical announce on November 13, 2026?
- Sino Biopharmaceutical has entered a multi-program partnership with Boehringer Ingelheim, covering six pre-clinical oncology biologics. The agreement involves $358 million in upfront payments and potential milestones totaling up to $7 billion, significantly impacting Sino Biopharmaceutical's investment narrative in oncology.
- What does Sino Biopharmaceutical do?
- Sino Biopharmaceutical is a leading biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative medical therapies.
- Which similar companies announced agreements around the same time?
- AbbVie Inc. (November 3, 2026), Teva Pharmaceutical Industries Ltd (November 3, 2026), Celltrion (October 26, 2026) and Edesa Biotech (November 9, 2026) also announced agreements within 45 days of Sino Biopharmaceutical.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Pharmaceutical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Incyte and Genmab Form Partnership to Explore New Treatment for KRAS G12D-Mutated Metastatic Colorectal Cancer. (October 24, 2026)
Agreement Insights
What this usually meansSino Biopharmaceutical signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.